Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,976.00
-44.00 (-2.18%)
At close: May 20, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 146.64 billion as of May 21, 2026. Its market cap has decreased by -55.90% in one year.
Market Cap
146.64B
Enterprise Value
230.00B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,976.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 146.64B, a decrease of -76.09%. That is a compound annual growth rate of -24.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 153.64B | -34.89% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korea Computer & Systems | 155.68B |
| Amosense | 155.61B |
| NBR Motion | 154.92B |
| DMS Co.,Ltd. | 154.15B |
| Kortek | 154.08B |
| T3 Entertainment | 153.57B |
| CS BEARING | 153.53B |
| ISU Abxis | 153.30B |